Medical 3D Printing and Bioprinting are considered as the future’s technologies, with a great investment potential which can be seen within any market analyses. We offer advantages to the investors who wish to grab future from where it starts.
Our Shares & Capital
HD Bioink was founded by Hakan DARICI, PhD, in January 2018 with an enterprise capital of 50.000 TRY (~12.500 USD). It was simultaneously supported by The Scientific and Technological Research Council of Turkey (TUBITAK) with an entrepreneurship project coded as BIGG with ~150.000 TRY (40.000 USD). Currently, Hakan DARICI is the sole owner of the shares.
